Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Shane William Charles Kovacs currently holds 139,727 shares of Olema Pharmaceuticals, Inc. (OLMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shane William Charles Kovacs has been a net seller of OLMA stock. They have purchased $0 and sold $7.8M worth of shares.
Shane William Charles Kovacs's most recent insider trade was on Jan 15, 2026, when they sold 100,000 shares at $28.73 per share.
Shane William Charles Kovacs serves as Executive at Olema Pharmaceuticals, Inc. (OLMA). They have executed 24 insider transactions totaling $7.8M over their tenure at the company.
Shane William Charles Kovacs holds the position of Executive at Olema Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Shane William Charles Kovacs has shown a selling trading pattern, with $0 in total purchases and $7.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Shane William Charles Kovacs was on May 22, 2015, when they sold $3.5M worth of PTCT shares. This transaction involved 64,041 shares at $55.26 per share.
Shane William Charles Kovacs currently owns 139,727 shares of Olema Pharmaceuticals, Inc. (OLMA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Shane William Charles Kovacs's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Shane William Charles Kovacs has 24 Form 4 filings on record as an insider at Olema Pharmaceuticals, Inc..
Set alerts for Shane William Charles Kovacs and 40,000+ other insiders.